DNA

Neuropathy No More Under Review: Blue Heron Health News’ Nerve Pain Relief Tips Guide

Natural Nerve Pain Relief Guide by Jodi Knapp Offers Holistic, Non-Pharmaceutical Approach to Peripheral Neuropathy—Emphasizing Gut Health, Lifestyle Changes, and…

9 months ago

BillionToOne Launches Expanded Panel for UNITY Fetal Risk™ Screen, Setting New Standard in Prenatal Testing

The new offering provides precise fetal risk assessment for up to 14 prevalent and actionable recessive and X-linked conditions, in…

9 months ago

BioHarvest Sciences Reports First Quarter 2025 Financial Results

First Quarter Revenues Grew 47% to $7.9 Million, Exceeding Management GuidanceRehovot, Israel--(Newsfile Corp. - May 15, 2025) - BioHarvest Sciences…

9 months ago

Nationwide to Introduce Kadance Precision Health Management Program

Kadance's program offers members access to genomics-based testing, medication optimization and personalized cancer support services to enhance policyholder value COLUMBUS,…

9 months ago

PAVmed Provides Business Update and Reports First Quarter 2025 Financial Results

Lucid secured capital to extend runway well past key upcoming reimbursement milestones; ended 1Q25 with over $40 million in proforma…

9 months ago

Lipella Pharmaceuticals to Present Phase 2a Data for LP-310 in Oral Lichen Planus at 2025 AAOM/EAOM International Meeting

Statistically significant safety and efficacy data from 0.25 mg and 0.50 mg cohorts to be presented Presentation scheduled for Thursday,…

9 months ago

Excision BioTherapeutics Announces Publication Highlighting EBT-107 for the Treatment of Chronic Hepatitis B in bioRxiv

Treatment with EBT-107 led to a rapid reduction in clinical biomarkers and suppression of random HBV DNA integration with minimal…

9 months ago

Plasmidsaurus Launches Fast, Low-Input AAV Genome Sequencing Service to Accelerate Gene Therapy R&D

SOUTH SAN FRANCISCO, Calif.  , May 14, 2025 /PRNewswire/ -- Plasmidsaurus, the company that sequences while you sleep, today announced…

9 months ago

UPDATE — Abeona Therapeutics® and Lurie Children’s Open First Center for ZEVASKYN™ Gene Therapy to Treat Wounds in Painful Skin Disorder

- ZEVASKYN, the first and only cell-based gene therapy for patients with recessive dystrophic epidermolysis bullosa (RDEB), now commercially available…

9 months ago

Targeted Genomics Announces Commercial Collaboration with OraSure Technologies for Direct to Consumer (DTC) Celiac Genetic Testing

IRVINE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Targeted Genomics LLC, developer of GlutenID, the first and only U.S. Food…

9 months ago